ArticleOncoimmunology2020

CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients' plasma as potential noninvasive biomarkers of disease activity.

Marie-Nicole Theodoraki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.